{"article_title": "Novartis Investigates China Bribery Allegations", "article_keywords": ["surveys", "second", "trials", "doctors", "allegations", "took", "novartis", "bribery", "china", "zurichnovartis", "report", "investigates", "problems", "staff"], "article_url": "http://www.wsj.com/articles/SB10001424127887324665604579081154070064832", "article_text": "ZURICH\u2014Novartis AG's eye-care division Alcon has opened an investigation into allegations that members of its Chinese staff bribed doctors at hundreds of hospitals in China, the second time the company has looked into possible problems at its China operations in as many months.\n\nAlcon employees paid doctors through a middleman for market surveys for clinical trials that never took place, according to a report in The 21st Century...", "article_metadata": {"article.template": "snippet", "article.created": "2013-09-17T17:32:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Novartis's eye-care division Alcon has opened an investigation into allegations that members of its Chinese staff bribed doctors at hundreds of hospitals in China, the second time the company has looked into possible problems at its China operations in as many months.", "creator": "@martafalconiWSJ", "image": {"alt": "Novartis eye-care division Alcon investigates allegations of bribery in China", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "title": "Novartis's Alcon Investigates China Bribery Allegations", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424127887324665604579081154070064832&headline=Novartis%20eye-care%20division%20Alcon%20investigates%20allegations%20of%20bribery%20in%20China&weburl=http://www.wsj.com/articles/SB10001424127887324665604579081154070064832"}}, "page.site.product": "WSJ", "keywords": "alcon,china pharmaceuticals,novartis,corporate crime,legal,judicial,new products,services,labor,personnel issues,corporate,industrial news,official trials,tests,bribery,political,general news,corruption,crime,courts,financial crime,content types,factiva filters,fc&e executive news filter,fc&e industry news filter,pharmaceuticals", "news_keywords": "alcon,china pharmaceuticals,novartis,corporate crime,legal,judicial,new products,services,labor,personnel issues", "article.headline": "Novartis eye-care division Alcon investigates allegations of bribery in China", "description": "Novartis's eye-care division Alcon has opened an investigation into allegations that members of its Chinese staff bribed doctors at hundreds of hospitals in China, the second time the company has looked into possible problems at its China operations in as many months.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424127887324665604579081154070064832&headline=Novartis%20eye-care%20division%20Alcon%20investigates%20allegations%20of%20bribery%20in%20China&weburl=http://www.wsj.com/articles/SB10001424127887324665604579081154070064832", "user.type": "nonsubscriber", "article.page": "Business", "page.content.format": "responsive", "article.summary": "Novartis's eye-care division Alcon has opened an investigation into allegations that members of its Chinese staff bribed doctors at hundreds of hospitals in China, the second time the company has looked into possible problems at its China operations in as many months.", "page.site": "wsj", "testkeys": "C", "article.published": "2013-09-17T17:32:00.000Z", "dj.asn": "i-db47", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "word_count": 369, "external_link_count": 2}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Novartis's eye-care division Alcon has opened an investigation into allegations that members of its Chinese staff bribed doctors at hundreds of hospitals in China, the second time the company has looked into possible problems at its China operations in as many months.", "title": "Novartis's Alcon Investigates China Bribery Allegations", "url": "http://www.wsj.com/articles/SB10001424127887324665604579081154070064832", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Marta Falconi", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Novartis\u2019s Alcon Investigates China Bribery Allegations", "article.type": "European Business News", "article.id": "SB10001424127887324665604579081154070064832", "user.exp": "default", "article.updated": "2013-09-17T17:32:00.000Z"}, "_id": "\"57477af46914bd0286fdca80\"", "article_summary": "Alcon employees paid doctors through a middleman for market surveys for clinical trials that never took place, according to a report in The 21st Century...\nZURICH\u2014Novartis AG's eye-care division Alcon has opened an investigation into allegations that members of its Chinese staff bribed doctors at hundreds of hospitals in China, the second time the company has looked into possible problems at its China operations in as many months."}